The sedation and immobilization of giraffe (Giraffa camelopardalis) is a tricky proposition due to a combination of problems often encountered in such procedures that can result in mortality or morbidity to the animal.1 Giraffes have a unique anatomy and physiology, making them one of the most challenging species to safely immobilize. Their large size makes them difficult to handle and their characteristically long neck, if not controlled, can create a danger to itself and the capture team.
The chemical immobilization of giraffe dates back to the 1960s, when succinylcholine was used to paralyze animals.2Since then, many advances have been made in the refinement of drug combinations used; today, giraffes can safely be captured, walked into trailers and transported due to the dedicated work of researchers, wildlife managers and veterinarians in the field.
There is one species of giraffe (Giraffa camelopardalis) with nine subspecies currently recognized. There are three subspecies which are the most wide-ranging and typically encountered by wildlife managers, usually in sub-Saharan nations such as Kenya and Namibia:
Giraffa camelopardalis tippelskirchi - Commonly called the Maasai giraffe, this subspecies is native to central and southern Kenya.
Giraffa camelopardalis reticulate - Called the Reticulated or Somali giraffe, this subspecies is found in northern parts of Kenya
Giraffa camelopardalis rothschildi - The Rothschild, Baringo or Ugandan giraffe is usually found in protected areas of Kenya including Mt. Elgon, Ruma and lake Nakuru National Parks, Mwea national reserve and several private conservancies/facilities.3
Immobilization in the giraffe is a challenge because of its unique anatomy and physiology. These present inherent problems during chemical restraint, including:
While it may be self-evident at this point, the size of the giraffe features prominently in the success of any capture procedure, and smaller animals tend to have better a success rate than the larger adults, since the former are more easily immobilized and restrained.2,3
While the immobilization and capture protocols for large wild animals share many similarities, the capture of giraffes is a complex and dangerous procedure, requiring the capture team to plan and organize the actions that the operation requires. It is critical that the capture is well-coordinated. Prior to darting a giraffe, the veterinarian must ensure that all equipment, blind folds, ropes, water and personnel are ready. He or she must also give instructions to the team including human safety issues to avoid any complications during the operation.3 Ideally, the capture team should have a chase vehicle that can get to the darted animal without any delays. If the capture is for translocation, the capture team must have a suitably designed field recovery crate for retrieval and short distance transport to the holding facility. Reversal drugs must be prepared ahead of time and be ready for administration immediately after the animal goes down.
Terrain is an important factor in capturing giraffes, with the ideal terrain being flat or open areas that will allow the capture team to physically bring down the animal when it is sufficiently anesthetized. Darting is typically executed from a vehicle or helicopter. In some cases, darting can be done on foot if the animal is approachable. Darting sites from a helicopter include the rump and back of the hind legs; from the ground (on foot or from a vehicle), the best sites are the shoulder and hindquarters.3 The neck should be avoided. Signs of induction include the giraffe attempting to flee at a markedly slowed pace, stumbling as it runs, holding the head high, drooping of ears and lifting of the muzzle.
The objective during any giraffe capture is to achieve a fast and efficient immobilization with a high dose of the opioid, which is reversed as soon as the animal is down. Longer immobilization times can result in hypoxia and death. According to Kenya Wildlife Service, thiofentanil can be used without a tranquilizer; azaperone can be used with care, as it cannot be reversed. Excessive doses may result in the animal being disoriented and ataxic after the opioid has been reversed. Etorphine and thiofentanil can be combined at a ratio of 20%:80%.3
For the immobilization of giraffe, the Handbook of Wildlife Chemical Immobilization (Arnemo & Kreeger, 2018) recommends thiafentanil (20 mg for males, and 14 mg for females). This can be supplemented with 5 mg of thiafentanil if needed. For reversal, the authors recommend naltrexone (200 mg for males, and 140 mg for females). Alternatively, etorphine may be used at 16 mg for males, and 12 mg for females. This may be reversed with naltrexone at 10 mg for each mg of etorphine given.5
Chemical Immobilization of Wild and Exotic Animals (Nielsen, 1999) recommends etorphine in total dosages of 5 to 6 mg with 20 mg of xylazine, or carfentanil in total dosages of 8 mg with 10 mg of atropine and 100 mg of xylazine. The author also reports that in some regions of Africa, etorphine in total dosages of 8 to 10 mg has been used in adult giraffe.4
Once the animal is down, the giraffe’s neck should be extended to ensure the airway. The neck should also be supported by at least two capture personnel, with the head maintained above the rumen and the nose pointed down to facilitate drainage of any rumen or pharyngeal fluids.3
1Bush, M., D. Grobler and J. Raath. The Art and Science of Giraffe (Giraffa camilopardalis) Immobilization/Anesthesia by M. Bush, D.CG. Grobler and J.P. Raath; B0169.0102. (2002).